Skip to main content
. 2022 Nov 29;10(6):e02967-22. doi: 10.1128/spectrum.02967-22

TABLE 3.

Diagnostic test performances of smear microscopy, the Xpert MTB/RIF assay, digital radiography, and TB symptomsd

Test or result Performance (%) (95% CI), no. of positive participants/total no. of participants tested
Cohen’s κ
Sensitivity Specificity PPV NPV
Smear microscopy 20.00 (8.07–41.60), 4/20 99.94 (99.63–99.99), 1,543/1,544 80.00 (37.56–96.38), 4/5 98.97 (98.34–99.37), 1,543/1,559 0.317
Xpert MTB/RIF 80.00 (58.40–91.93), 16/20 99.87 (99.53–99.96), 1,542/1,544 88.89 (67.20–96.90), 16/18 99.74 (99.34–99.90), 1,542/1,546 0.840
Chest radiography 45.00 (25.82–65.79), 9/20 95.98 (94.89–96.85), 1,482/1,544 12.68 (6.82–22.37), 9/71 99.26 (98.69–99.59), 1,482/1,493 0.182
TB symptoms 5.00 (0.88–23.61), 1/20 98.83 (98.16–99.26), 1,526/1,544 5.26 (0.93–24.64), 1/19 98.77 (98.09–99.21), 1,526/1,545 0.039
TB symptom positive or chest radiography positivea 45.00 (25.82–65.79), 9/20 95.92 (94.81–96.80), 1,481/1,544 12.50 (6.72–22.08), 9/72 99.26 (98.68–99.59), 1,481/1,492 0.179
Smear microscopy positive or Xpert MTB/RIF assay positive 80.00 (58.40–91.93), 16/20 99.81 (99.43–99.93), 1,541/1,544 84.21 (62.44–94.48), 16/19 99.74 (99.34–99.90), 1,541/1,545 0.818
Smear microscopy positive or chest radiography positive 60.00 (38.66–78.12), 12/20 95.92 (94.81–96.80), 1,481/1,544 16.00 (9.40–25.92), 12/75 99.46 (98.94–99.73), 1,481/1,489 0.237
Xpert MTB/RIF positive or chest radiography positive 90.00 (69.90–97.21), 18/20 95.98 (94.89–96.85), 1,482/1,544 22.50 (14.73–32.79), 18/80 99.87 (99.51–99.96), 1,482/1,484 0.347
Smear microscopy positive, Xpert MTB/RIF assay positive, or chest radiography positive 90.00 (69.90–97.21), 18/20 95.92 (94.81–96.80), 1,481/1,544 22.22 (14.54–32.41), 18/81 99.87 (99.51–99.96), 1,481/1,483 0.343
Smear microscopy followed by Xpert MTB/RIFb 80.00 (58.40–91.93), 16/20 99.81 (99.43–99.93), 1,541/1,544 84.24 (62.44–94.48), 16/19 99.74 (99.34–99.90), 1,541/1,545 0.818
Smear microscopy followed by chest radiography and symptomsb followed by Xpert MTB/RIF assayc 50.00 (29.93–70.07), 10/20 99.81 (99.43–99.93), 1,541/1,544 76.92 (49.75–91.82), 10/13 99.36 (98.82–99.65), 1,541/1,551 0.602
Chest radiography and symptoms followed by Xpert MTB/RIF assayc 35.00 (18.12–56.17), 7/20 99.87 (99.53–99.96), 1,542/1,544 77.78 (45.26–93.68), 7/9 99.16 (98.57–99.51), 1,542/1,555 0.479
Chest radiography and symptoms followed by smear microscopyc followed by Xpert MTB/RIF assayb 35.00 (18.12–56.17), 7/20 99.87 (99.53–99.96), 1,542/1,544 77.78 (45.26–93.68), 7/9 99.16 (98.57–99.51), 1,542/1,555 0.479
a

WHO-recommended algorithm.

b

Performed if smear negative.

c

Performed if digital radiography results were compatible with active TB or TB symptoms.

d

CI, confidence interval; PPV, positive predictive value; NPV, negative predictive value.